• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: PENUMBRA, INC. BENCHMARK 6F 071 DELIVERY CATHETER; DQY, QJP

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

PENUMBRA, INC. BENCHMARK 6F 071 DELIVERY CATHETER; DQY, QJP Back to Search Results
Catalog Number BMK6F105M
Medical Device Problem Code Leak/Splash (1354)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 12/05/2023
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
This device is available for return.A follow up mdr will be submitted upon completion of the device investigation.H3 other text : placeholder.
 
Event or Problem Description
The patient was undergoing a coil embolization procedure in the internal carotid artery (ica) using a benchmark 6f 071 delivery catheter (benchmark), and a sheath.During the procedure, the physician placed the benchmark into the carotid artery using the sheath.While aspirating blood from the benchmark using a syringe prior to performing an angiography, the physician noticed air leaking at the proximal end of the benchmark.Therefore, the benchmark was removed.The procedure was completed using a new benchmark and the same sheath.There was no report of an adverse effect to the patient.
 
Additional Manufacturer Narrative
Please note that the device associated with this complaint was expected to be returned; however, the device was lost in transit and is no longer available for return.Therefore, without the return of the device, the root cause of the problem cannot be determined.The manufacturing records for this lot were reviewed and did not reveal any outstanding discrepancies, design, or quality concerns.
 
Additional Manufacturer Narrative
Please note that the following section was incorrectly reported on the initial mfr report and is being corrected on this follow-up # 2 mfr report: 1.Section d.Box 4.Unique identifier.H3 other text : placeholder.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BENCHMARK 6F 071 DELIVERY CATHETER
Common Device Name
DQY, QJP
Manufacturer (Section D)
PENUMBRA, INC.
one penumbra place
alameda CA 94502
Manufacturer Contact
veronica farris
one penumbra place
alameda, CA 94502
5107483200
MDR Report Key18422770
Report Number3005168196-2023-00580
Device Sequence Number12452748
Product Code DQY
UDI-Device Identifier00814548014043
UDI-Public00814548014043
Combination Product (Y/N)N
Initial Reporter CountryUK
PMA/510(K) Number
K212838
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date (Section B) 06/14/2024
Report Date (Section F) 01/01/2005
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date07/31/2026
Device Catalogue NumberBMK6F105M
Device Lot NumberF00007759
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? Yes
Date Report to Manufacturer01/10/2005
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 12/08/2023
Supplement Date Received by Manufacturer03/19/2024
01/14/2005
Initial Report FDA Received Date12/30/2023
Supplement Report FDA Received Date04/09/2024
06/14/2024
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured08/01/2023
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient Age51 YR
Patient SexFemale
Date Report Sent to FDA01/01/2005
-
-